glp-1 drugs names types of glp 1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? Complete List & Comparison Guide
Description
FDA-approved options include Wegovy (semaglutide, chronic weight management), Ozempic (semaglutide, type 2 diabetes), Zepbound (tirzepatide, chronic weight management), and Mounjaro (tirzepatide, type 2 diabetes)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Based on the above pharmacological characteristics of categories of GLP-1RAs agents, despite slight adverse gastrointestinal side effects, it is clear that GLP-1RAs agents have efficacy in cardiovascular protection without untoward hypoglycemia
The same receptor activation that increases heart rate also drives some of the most potent cardiovascular benefits
Many involve well-known side effects like nausea, vomiting, diarrhea, and gallbladder problems
